Published in BMC Cancer on September 09, 2016
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88
Identification of human brain tumour initiating cells. Nature (2004) 38.87
Identification and expansion of human colon-cancer-initiating cells. Nature (2006) 24.44
The clonal evolution of tumor cell populations. Science (1976) 24.39
Efficient tumour formation by single human melanoma cells. Nature (2008) 16.35
Identification of cells initiating human melanomas. Nature (2008) 8.28
A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res (2005) 7.86
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res (2006) 6.77
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell (2010) 6.47
CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res (2007) 6.21
Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell (2012) 5.44
Cancer stem cells: current status and evolving complexities. Cell Stem Cell (2012) 5.07
Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature (2010) 5.05
Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer (2007) 3.80
Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell (2010) 3.70
In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res (2008) 3.66
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res (2005) 3.52
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer (2008) 3.46
Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res (2009) 2.93
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest (2008) 2.79
Increased expression of stem cell markers in malignant melanoma. Mod Pathol (2006) 2.39
Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res (2011) 2.08
Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer Res (2010) 1.76
The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells (2008) 1.70
ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells (2012) 1.70
Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol Cancer Res (2009) 1.69
Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res (2008) 1.65
CD133 is a marker of bioenergetic stress in human glioma. PLoS One (2008) 1.63
VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth. Cancer Res (2011) 1.62
Characterization of melanoma cells capable of propagating tumors from a single cell. Cancer Res (2010) 1.50
Melanoma stem cells: the dark seed of melanoma. J Clin Oncol (2008) 1.37
CD133 expression predicts for non-response to chemotherapy in colorectal cancer. Mod Pathol (2010) 1.29
Glioma cell populations grouped by different cell type markers drive brain tumor growth. Cancer Res (2010) 1.24
Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma. PLoS One (2010) 1.15
Systematic classification of melanoma cells by phenotype-specific gene expression mapping. Pigment Cell Melanoma Res (2012) 1.14
CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry. Cancer Res (2012) 1.13
Embryonic stem cell markers. Molecules (2012) 1.13
The Ludwig institute for cancer research Melbourne melanoma cell line panel. Pigment Cell Melanoma Res (2013) 1.08
GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells. Pigment Cell Melanoma Res (2011) 1.06
Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1α-dependent manner in pancreatic cancer cells. Pathobiology (2011) 1.03
CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway. Histopathology (2012) 1.00
Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications. PLoS One (2010) 0.98
CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133- cells. Lab Invest (2011) 0.97
Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis. Mod Pathol (2010) 0.93
The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells. PLoS One (2014) 0.92
Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells. Neuromolecular Med (2012) 0.92
Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer. Gastric Cancer (2013) 0.92
Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells. Pigment Cell Melanoma Res (2010) 0.91
Functional features of cancer stem cells in melanoma cell lines. Cancer Cell Int (2013) 0.90
MITF and PAX3 Play Distinct Roles in Melanoma Cell Migration; Outline of a "Genetic Switch" Theory Involving MITF and PAX3 in Proliferative and Invasive Phenotypes of Melanoma. Front Oncol (2013) 0.84
Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile. Stem Cells (2012) 0.84
Glioblastoma cells negative for the anti-CD133 antibody AC133 express a truncated variant of the CD133 protein. Int J Mol Med (2010) 0.83
In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines. Exp Hematol Oncol (2013) 0.82
A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors. Pathology (2011) 0.80
A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells. Front Genet (2013) 0.78